SIRION Biotech
AcquiredMunich, Germany · Founded 2003
- Headquarters
- Munich
- Founded
- 2003
- Business Model
- B2B
- Website
- sirion-biotech.com
- Last Round
- Seed
- Rounds
- 2
- Acquired by
- PerkinElmerJun 2021
About
SIRION Biotech GmbH was a Munich, Germany-based biotech company, founded in 2003, that developed vector-based technologies -- including AAV, lentivirus, and adenovirus platforms -- for cell and gene therapy research, drug discovery, and preclinical development. In 2021 it was acquired by PerkinElmer (now Revvity); its viral vector expertise and 20+ years of gene delivery experience now live on within Revvity's Gene Delivery business unit.
Summary
SIRION Biotech is a Biotech company based in Munich, Germany, founded in 2003. Investors include High-Tech Grunderfonds, Creathor Ventures and Bayern Kapital.
Funding History
Jun 2021
Sign up to see all 3 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sirion-biotech"><img src="https://indexed.vc/api/badge/company/sirion-biotech" alt="SIRION Biotech on Indexed.vc" width="260" height="76" /></a>